Lantern Pharma Announces Webinar on Open‑Medicine AI Platform

What Happened Lantern Pharma, Inc. (LTRN) filed a Form 8‑K on September 23, 2026 disclosing that it will issue a press release and host a live webinar on September 23, 2026 to discuss Open‑Medicine AI, its multi‑agentic AI platform for drug development. The press release is furnished as Exhibit 99.1 to the 8‑K and is incorporated by reference.

Key Details

• Filing date: September 23, 2026 (Form 8‑K, Item 7.01 Regulation FD Disclosure).
• Event: Live webinar on September 23, 2026 to discuss the Open‑Medicine AI platform (multi‑agentic AI for drug development).
• Disclosure: Press release describing webinar topics is furnished as Exhibit 99.1 to the Form 8‑K.
• Technical exhibits: the filing also references Inline XBRL cover page data (Exhibit 104 / contained in Exhibit 101).

Why It Matters This filing is an informational Regulation FD disclosure announcing a scheduled investor/public presentation about Lantern Pharma’s AI drug‑development platform. It gives investors a direct opportunity to hear company updates on Open‑Medicine AI; the 8‑K does not report financial results, executive changes, mergers, or other material transactional events. Investors seeking more detail should review the press release (Exhibit 99.1) and consider attending the webinar or watching any replay the company provides.